CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes

Hepatology

Volumn 49, Issue 3, 2009, Pages 753-762

  Ye, Li ^a   Wang, Xu ^a   Wang, Shihong ^a   Wang, Yanjian ^a   Song, Li ^a   Hou, Wei ^a   Zhou, Lin ^a,b   Li, He ^b   Ho, Wenzhe ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR; JANUS KINASE; STAT PROTEIN; ALPHA INTERFERON; BETA INTERFERON; VIRUS RNA;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CD56+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE SEQUENCE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTIVITY; VIRUS REPLICATION; CELL COMMUNICATION; CELL CULTURE; CELL LINE; COCULTURE; CYTOLOGY; FEMALE; GENETICS; HEPATITIS C; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANTIGENS, CD56; CELL COMMUNICATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; JANUS KINASES; MALE; RNA, VIRAL; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 63349096722     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22715     Document Type: Article

References (41)

1. Schmidt RE, Murray C, Daley JF, Schlossman SF, Ritz J. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med 1986;164:351-356.
2. Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum Immunol 2006;67:863-873.
3. + T cells. Immunology 2001;103:281-290.
4. Loza MJ, Metelitsa LS, Perussia B. NKT and T cells: Coordinate regulation of NK-like phenotype and cytokine production. Eur J Immunol 2002;32: 3453-3462.
5. Jin Y, Fuller L, Carreno M, Esquenazi V, Tzakis AG, Miller J. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. Hum Immunol 1998;59:352-362.
6. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-2321.
7. + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994;153:1687-1696.
8. Kronenberg M. Toward an understanding of NKT cell biology: Progress and paradoxes. Annu Rev Immunol 2005;23:877-900.
9. Meresse B, Curran SA, Ciszewski C, Orbelyan G, Setty M, Bhagat G, et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 2006;203:1343-1355.
10. Deignan T, Curry MP, Doherty DG, Golden-Mason L, Volkov Y, Norris S, et al. Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 2002;37:101-108.
11. Norris S, Doherty DG, Curry M, McEntee G, Traynor O, Hegarty JE, et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother 2003;52:53-58.
12. Koreck A, Suranyi A, Szony BJ, Farkas A, Bata-Csorgo Z, Kemeny L, et al. CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 2002;127:176-182.
13. Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Cancer Immun 2008;8:10.
14. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000;174:5-20.
15. Vitale M, Caruso A, Licenziati S, Rodella L, Fiorentini S, Zauli G, et al. Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects. Cytometry 2000;39:189-194.
16. Golden-Mason L, Castelblanco N, O'Farrelly C, Rosen HR. Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection. J Virol 2007;81:9292-9298.
17. +)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. HEPATOLOGY 2000; 32:962-969.
18. Okumura A, Ishikawa T, Maeno T, Sato K, Ayada M, Hotta N, et al. Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma. Hepatol Res 2005;32:213-217.
19. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-796.
20. +T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells. J Infect Dis 2005;192:1093-1101.
21. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis 1998;178:1189-1192.
22. Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, et al. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. HEPATOLOGY 2005;42:819-827.
23. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007;449:919-922.
24. Castet V, Fournier C, Soulier A, Brillet R, Coste J, Larrey D, et al. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. J Virol 2002;76:8189-8199.
25. Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, et al. Primary human hepatocytes in spheroid formation to study hepatitis C infection. J Surg Res 2006;130:52-57.
26. Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, et al. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 2007;170:478-489.
27. Ami K, Ohkawa T, Koike Y, Sato K, Habu Y, Iwai T, et al. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18. Clin Exp Immunol 2002;128:453-459.
28. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004;75: 163-189.
29. Subramaniam PS, Green MM, Larkin J III, Torres BA, Johnson HM. Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. J Interferon Cytokine Res 2001;21:951-959.
30. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006;25:349-360.
31. Park MK, Amichay D, Love P, Wick E, Liao F, Grinberg A, et al. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J Immunol 2002;169:1433-1443.
32. Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ. Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 2004;76:1171-1179.
33. Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. HEPATOLOGY 2002;35:694-703.
34. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, et al. Comparative analysis of anti-hepatitisCvirus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 2002;76:11148-11154.
35. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001;75:8516-8523.
36. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005;5:375-386.
37. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A 2006;103:15136-15141.
38. Ozato K, Tailor P, Kubota T. The interferon regulatory factor family in host defense: Mechanism of action. J Biol Chem 2007;282:20065-20069.
39. Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: New insights into IFN networks. Trends Immunol 2005;26:396-401.
40. van Boxel-Dezaire AH, Rani MR, Stark GR. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006; 25:361-372.
41. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005;309:1577-1581.